Laboratory Corporation of America Holdings (NYSE:LH)'s Chairman, Chief Executive Officer and President David P. King recently stated,"Growing in women's health, genetics and medical drug monitoring, which are areas that we have been investing in to sustain and support our growth in terms of instrumentation, sales force, capabilities and where we've seen a significant organic growth year-on-year continuing to pursue accretive acquisitions. And obviously, unspoken but critical is our constant focus on quality, service and innovation."